CIK 0000879169 · Large accelerated filer
INCYTE CORP
Sign in to watch- Ticker
- INCY
- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 943136539
- Phone
- 3024986700
- Business address
- 1801 AUGUSTINE CUT-OFF, WILMINGTON, DE, 19803
- Former names
- INCYTE INC, INCYTE GENOMICS INC, INCYTE PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $32,959,897
- in 5 filings, $33.0M under 10b5-1 plans
Net −$32,959,897. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-01 | Morrissey Michael James EVP, Head of Tech. Operations | Shares withheld for taxes | −326 | $102.04 | $33K | 85,838 |
| 2025-12-01 | Stein Steven H EVP & Chief Medical Officer | Sale 10b5-1 | −2,559 | $102.96 | $263K | 100,327 |
| 2025-12-01 | Stein Steven H EVP & Chief Medical Officer | Shares withheld for taxes 10b5-1 | −17,093 | $102.04 | $1.7M | 83,234 |
| 2025-11-24 | Tray Thomas Principal Accounting Officer | Sale 10b5-1 | −600 | $103.00 | $62K | 23,573 |
| 2025-11-21 | Tray Thomas Principal Accounting Officer | Sale 10b5-1 | −169 | $102.00 | $17K | 24,173 |
| 2025-11-17 | Denton Sheila A. EVP & General Counsel | Option exercise 10b5-1 | +278 | $64.25 | $18K | 26,847 |
| 2025-11-17 | Denton Sheila A. EVP & General Counsel | Sale 10b5-1 | −278 | $104.36 | $29K | 26,569 |
| 2025-11-17 | Denton Sheila A. EVP & General Counsel | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −278 | 8,883 | ||
| 2025-11-10 | Hoppenot Herve Director | Sale 10b5-1 | −187,500 | $105.46 | $19.8M | 329,646 |
| 2025-11-05 | Stein Steven H EVP & Chief Medical Officer | Option exercise 10b5-1 | +1,194 | $83.83 | $100K | 104,080 |
| 2025-11-05 | Stein Steven H EVP & Chief Medical Officer | Option exercise 10b5-1 | +2,995 | $95.76 | $287K | 107,075 |
| 2025-11-05 | Stein Steven H EVP & Chief Medical Officer | Option exercise 10b5-1 | +1,044 | $95.76 | $100K | 108,119 |
| 2025-11-05 | Stein Steven H EVP & Chief Medical Officer | Sale 10b5-1 | −5,233 | $102.20 | $535K | 102,886 |
| 2025-11-05 | Stein Steven H EVP & Chief Medical Officer | Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 | −1,194 | 0 | ||
| 2025-11-05 | Stein Steven H EVP & Chief Medical Officer | Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 | −2,995 | 0 | ||
| 2025-11-05 | Stein Steven H EVP & Chief Medical Officer | Option exercise · Incentive Stock Option (right to buy) 10b5-1 | −1,044 | 0 | ||
| 2025-11-04 | Denton Sheila A. EVP & General Counsel | Option exercise 10b5-1 | +598 | $58.06 | $35K | 27,167 |
| 2025-11-04 | Denton Sheila A. EVP & General Counsel | Sale 10b5-1 | −598 | $101.36 | $61K | 26,569 |
| 2025-11-04 | Denton Sheila A. EVP & General Counsel | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −598 | 13,765 | ||
| 2025-11-03 | Heeson Lee EVP, Head of Incyte Intl | Sale 10b5-1 | −3,074 | $94.02 | $289K | 29,241 |
Page 14 of 15 · 293 trades